C&C Group plc (LON:CCR)
London · Delayed Price · Currency is GBP · Price in GBX 173.80
-3.40 (-1.92%)
Aug 1, 2025, 4:35 PM BST
Revance Therapeutics Market Cap
C&C Group has a market cap or net worth of 644.09 million as of August 1, 2025. Its market cap has increased by 6.53% in one year.
Market Cap
644.09M
Enterprise Value
820.20M
Revenue
1.38B
Ranking
n/a
PE Ratio
60.06
Stock Price
$173.80
Market Cap Chart
Since October 7, 2019, C&C Group's market cap has decreased from 1.18B to 644.09M, a decrease of -45.23%. That is a compound annual growth rate of -9.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 644.09M | 16.55% |
| Dec 31, 2024 | 552.61M | -7.75% |
| Dec 29, 2023 | 599.03M | -12.72% |
| Dec 30, 2022 | 686.31M | -24.43% |
| Dec 31, 2021 | 908.21M | 28.98% |
| Dec 31, 2020 | 704.12M | -43.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unilever | 109.82B |
| British American Tobacco p.l.c. | 88.30B |
| Diageo | 41.18B |
| Reckitt Benckiser Group | 37.83B |
| Tesco | 27.72B |
| Imperial Brands | 23.94B |
| Associated British Foods | 15.53B |
| Coca-Cola HBC AG | 14.34B |